Macular Dystrophy

2

Review clinical trials related to Macular Dystrophy. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

High Resolution, High-speed Multimodal Ophthalmic Imaging

Knowledge of the pathogenesis of ocular conditions, a leading cause of blindness, has benefited greatly from recent advances in ophthalmic imaging. However, current clinical imaging systems are limited in resolution, speed, or access to certain structures of the eye. The use of a high-resolution imaging system improves the resolution of ophthalmoscopes by several orders of magnitude, allowing the visualization of many microstructures of the eye: photoreceptors, vessels, nerve bundles in the retina, cells and nerves in the cornea. The use of a high-speed acquisition imaging system makes it possible to detect functional measurements such as the speed of blood flow. The combination of data from multiple imaging systems to obtain multimodal information is of great importance for improving the understanding of structural changes in the eye during a disease. The purpose of this project is to observe structures that are not detectable with routinely used systems.

Participants needed: 1,200
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: Centre Hospitalier National d'Ophtalmologie des Quinze-VingtsUpdated: Nov 18, 2025Locations: 1
Eligibility criteria

People over 18 [+3]

Patients with a history of photosensitivity. [+10]

Status: Not yet recruiting

Correlation Between OCT and Mf-ERG Findings With BCVA in Patients With Macular Dystrophy

Correlation between optical coherence tomography and multifocal electroretinogram findings with visual acuity in patients with macular dystrophy.

Participants needed: 30
Trial details
Biological sex: AllType: ObservationalSponsor: New Valley UniversityUpdated: Sep 12, 2025
Eligibility criteria

All patients diagnosed with macular dystrophy in Tiba Eye Centre, Egypt, Assiut,...

The patients diagnosed with macular dystrophy refuse to contribute to the study.